"Several pharmaceutical companies have said they will sell drugs direct to patients in the U.S. and offered discounts following President Donald Trump's calls to bring down drug prices and cut out "middlemen" like pharmacies, insurers and pharmacy benefit managers. The Trump administration announced on Tuesday plans to launch a government-run website called TrumpRx.gov in early 2026, offering reduced prices for prescription drugs."
"U.S. patients currently pay by far the most for prescription medicines, often nearly three times more than in other developed nations. Trump sent letters to 17 major companies in July demanding they slash U.S. prescription drug prices. Below is an overview of pharmaceutical companies which recently announced direct-to-consumer sales and price cuts in the U.S: PFIZER Pfizer and President Donald Trump said on Tuesday they had cut a deal in which the U.S.-based drugmaker agreed to lower prescription drug prices"
Several major pharmaceutical companies announced plans to sell prescription medicines directly to U.S. patients and offer discounts to bypass pharmacies, insurers and pharmacy benefit managers. The Trump administration plans to launch a government-run website called TrumpRx.gov in early 2026 to offer reduced drug prices. U.S. patients pay substantially more for medicines than other developed nations, often nearly three times more. Pfizer agreed to lower Medicaid prices to match what it charges in other developed countries in exchange for tariff relief and pledged $70 billion for R&D and domestic manufacturing. PhRMA will launch AmericasMedicines.com to help patients buy directly from manufacturers. Novo Nordisk set a $499 monthly cash price for Ozempic for eligible type 2 diabetes patients and has worked with telehealth partners to sell Wegovy.
Read at Fast Company
Unable to calculate read time
Collection
[
|
...
]